Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-072801·Aardvark Therapeutics, Inc.
Schedule 13G ownership disclosure
Aardvark Therapeutics Inc
Common Stock, par value $0.00001 · CUSIP: 002942100
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Tien-Li Lee
Shares: 2,983,724 · Class: 13.7%
- Jane Wu Lee
Shares: 2,983,724 · Class: 13.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072801
- Form type
- SCHEDULE 13G
- Filer
- Aardvark Therapeutics, Inc.
- CIK
- CIK 1774857
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership